Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The glypicans constitute a growing family of cell surface heparan sulfate proteoglycans that may play a role in the control of cell division and growth regulation. Recently, deletions and translocations involving GPC3 (the gene for glypican-3, localized on Xq26) have been identified in patients with Simpson-Golabi-Behmel syndrome (SGBS). This X-linked syndrome is characterized by pre- and postnatal overgrowth, visceral and skeletal abnormalities, and a high risk for the development of embryonal tumors, mostly Wilms tumor and
neuroblastoma
. In the present report we show that the gene for human K-glypican/
glypican-4
(
GPC4
) also maps to Xq26, centromeric to GPC3. The
glypican-4
protein is encoded by nine exons. Establishment of a BAC/PAC contig physically linking
GPC4
and GPC3 indicates that these two genes are arranged in a tandem array, the 5' end of
GPC4
flanking the 3' end of GPC3. Unlike the glypican-3 message, the
glypican-4
message is nearly ubiquitous. Analysis of DNA samples from eight patients with diagnosis of SGBS identified one individual with a deletion that involves the entire
GPC4
gene and the last two exons of GPC3. The tight clustering of GPC3 and
GPC4
, with deletions that occasionally affect both genes, may be relevant for explaining the variability of the SGBS phenotype.
...
PMID:GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. 978 72